{"nct_id":"NCT02426125","title":"A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer","status":"COMPLETED","status_verified_date":"2023-08","start_date":"2015-07-13","start_date_type":"ACTUAL","primary_completion_date":"2017-04-21","primary_completion_date_type":"ACTUAL","completion_date":"2022-07-26","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}